Inaktiver Wert

Andere Sprachen Therapix Biosciences Ltd. Nasdaq

Aktien

A2DQGR

US88339A2033

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
SciSparc Ltd. Receives Another Patent, Strengthening its Core Technology in Canada	18.03.
SciSparc Ltd. Announces Successfully Dosed the First Patient in Its SCI-210 Clinical Trial At the Soroka Medical Center for Pediatric Patients	14.03.
Top Premarket Gainers	08.03.
SciSparc Ltd. Announces Enrollment of First Patient for Its Clinical Trial for Children with Autism Spectrum Disorder	08.03.
Scisparc Ltd. Granted Patent for Core Technology in Multiple Jurisdictions in Europe	07.03.
SciSparc Ltd. Receives Canadian Patent for Opioids Reduction Use in Pain Management Technology	06.03.
SciSparc Ltd. Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing	29.02.
Scisparc Initiates Autism Spectrum Disorder Study	29.01.
Top Midday Decliners	29.01.
Scisparc Ltd. Announces Initiation of Patient Recruitment for Its Clinical Trial with Sci-210 in Children with Autism Spectrum Disorder	29.01.
Top Midday Gainers	24.01.
SciSparc Ltd. and Clearmind Medicine Inc. Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments	04.01.
Scisparc Ltd. and Clearmind Medicine Inc. Announces Obesity Drug Showed Positive Results in A Pre-Clinical Trial	01.12.
SciSparc Ltd. Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment	28.11.
Top Gainers	24.11.
Sector Update: Health Care Stocks Higher Friday Afternoon	24.11.
Sector Update: Health Care	24.11.
SciSparc Launches Clinical Trial of CBD-Based Drug for Autism in Children	24.11.
SciSparc Signs Letter of Intent to Merge With Vehicle Importer in Israel	22.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Therapix Biosciences Ltd. Nasdaq

Aktien

A2DQGR

US88339A2033

Andere Sprachen

Filter